Showing 741 - 760 results of 43,973 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.70s Refine Results
  1. 741
  2. 742

    Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

    Published 2009
    “…<p>(A) RFF is decreased by alterations in heart rate. …”
  3. 743
  4. 744
  5. 745
  6. 746
  7. 747
  8. 748
  9. 749

    Decreased Tks5 expression results in neural crest-derived defects. by Danielle A. Murphy (212554)

    Published 2011
    “…(C) Melanophores present in the dorsal, ventral, and lateral pigment lines were quantified to determine degree of murine Tks5 rescue of the decreased pigmentation seen in morphants. …”
  10. 750

    Increases in 1,5-anhydrosorbitol and decreases in ascorbic acid following RYGB. by David M. Mutch (37665)

    Published 2013
    “…Furthermore, symbols and numbers are consistently used for the same subject in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007905#pone-0007905-g004" target="_blank">Figures 4</a> & <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007905#pone-0007905-g005" target="_blank">5</a>. Mean metabolite abundance±SEM is indicated in red. …”
  11. 751
  12. 752
  13. 753
  14. 754
  15. 755
  16. 756

    GluN2A(D731N) decreases channel open probability. by Kai Gao (120150)

    Published 2017
    “…The di-heteromeric mutant (2A-D731N) and tri-heteromeric receptors with two-copies of the mutant subunit (D731N/D731N) showed a prolonged inhibition rate, reflecting a decreased channel open probability. …”
  17. 757
  18. 758
  19. 759
  20. 760

    A Novel Highly Potent Autotaxin/ENPP2 Inhibitor Produces Prolonged Decreases in Plasma Lysophosphatidic Acid Formation <i>In Vivo</i> and Regulates Urethral Tension by Hiroshi Saga (584103)

    Published 2014
    “…To date, several autotaxin/ENPP2 inhibitors have been reported; however, none were able to completely and continuously inhibit autotaxin/ENPP2 <i>in vivo</i>. In this study, we report the discovery of a highly potent autotaxin/ENPP2 inhibitor, ONO-8430506, which decreased plasma lysophosphatidic acid formation.…”